Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Pivonello, Rosario; Petersenn, Stephan; Newell-Price, John; Findling, James; Gu, Feng; Maldonado, Mario; Trovato, Andrew; Hughes, Gareth; Salgado, Luiz; Lacroix, Andre; Schopohl, Jochen; Biller, Beverly

doi:10.1111/cen.12431

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Atıf İçin Kopyala

Pivonello R., Petersenn S., Newell-Price J., Findling J. W., Gu F., Maldonado M., ...Daha Fazla

CLINICAL ENDOCRINOLOGY, cilt.81, sa.3, ss.408-417, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 81 Sayı: 3
Basım Tarihi: 2014
Doi Numarası: 10.1111/cen.12431
Dergi Adı: CLINICAL ENDOCRINOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.408-417
İstanbul Üniversitesi Adresli: Hayır

Özet

Objective Signs and symptoms of Cushing's disease are associated with high burden of illness. In this analysis, we evaluated the effect of pasireotide treatment on signs and symptoms in patients with Cushing's disease.